Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Underweight women with PCOS can have insulin resistance, and treatment with metformin and dexamethasone can improve symptoms.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Women with PCOS have hormonal imbalances and increased central obesity, highlighting the need for early detection and management.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Cats can have hypersomatotropism without diabetes, suggesting current diagnosis methods may miss cases.

A patient with myotonic dystrophy had several autoimmune disorders and thyroid cancer, suggesting a possible link between these conditions.

Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

GLP-1 agonists may increase the risk of hair loss.

Improved nutrition quickly healed the patient's skin lesions.

A girl with type 1 diabetes developed a serious eye condition very early, suggesting the need for earlier eye checks and that early treatment can work well.

Type 1 Diabetes prevents hair growth by causing cell death in hair follicles.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

Finasteride may worsen blood sugar control in diabetic patients.

More research is needed to understand if GLP-1 agonists affect hair health.

MSUD patients need careful monitoring of amino acids and zinc to prevent severe symptoms.

Diabetics have lower chromium, manganese, and copper, but higher iron in their hair.

Diabetes can cause skin problems, so good skin care is important.

Obesity worsens metabolic issues in women with PCOS.

Hair loss and metabolic syndrome are linked, sharing causes and treatment options.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.